Passmore S J, Draper G, Brownbill P, Kroll M
Childhood Cancer Research Group, Oxford.
BMJ. 1998 Jan 17;316(7126):184-9. doi: 10.1136/bmj.316.7126.184.
To investigate the possible link between neonatal administration of intramuscular vitamin K and childhood cancer.
Ecological studies comparing incidence of cancer in groups of children classified by the vitamin K policy in operation at their hospital of birth.
Selected large maternity units in England, Scotland, and Wales.
Children born in these units in varying periods between 1966 and 1991.
Cancer occurring among these children before age 15 years identified by using the National Registry of Childhood Tumours. Ratios of observed to expected numbers of these conditions calculated for hospitals where the policy was to give all babies intramuscular vitamin K (non-selective) and where the policy was to use this treatment only for a selected minority of babies at increased risk of vitamin K deficiency bleeding (selective).
These ratios were calculated for children born in 94 hospitals with varying vitamin K policies. A raised risk was occasionally associated with vitamin K, but the overall results were not significant, and there was no evidence to support the previously suggested doubling of the risk of childhood cancer.
On the basis of the results reported here it is unlikely that there is a greatly increased risk of childhood cancer attributable to intramuscular vitamin K given to newborns, if indeed there is any.
研究新生儿肌内注射维生素K与儿童癌症之间可能存在的联系。
进行生态学研究,比较根据其出生医院所实施的维生素K政策分类的儿童群体中癌症的发病率。
英格兰、苏格兰和威尔士选定的大型产科单位。
1966年至1991年不同时期在这些单位出生的儿童。
通过使用国家儿童肿瘤登记处确定这些15岁以下儿童中发生的癌症。计算在政策是给所有婴儿肌内注射维生素K(非选择性)的医院以及政策是仅对维生素K缺乏性出血风险增加的少数选定婴儿使用这种治疗方法(选择性)的医院中,这些疾病的观察数与预期数的比率。
计算了在94家实施不同维生素K政策的医院中出生的儿童的这些比率。维生素K偶尔会增加风险,但总体结果不显著,并且没有证据支持先前提出的儿童癌症风险加倍的说法。
根据此处报告的结果,新生儿肌内注射维生素K导致儿童癌症风险大幅增加的可能性不大,即便确实存在任何风险。